{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:08:26Z","timestamp":1774858106845,"version":"3.50.1"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Cystic fibrosis (CF) is a genetic ailment caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This autosomal recessive disorder is characterized by diverse pathobiological abnormalities, such as the disorder of CFTR channels in mucosal surfaces, caused by inadequate clearance of mucus and sputum, in addition to the malfunctioning of mucous organs. However, the primary motive of mortality in CF patients is pulmonary failure, which is attributed to the colonization of opportunistic microorganisms, formation of resistant biofilms, and a subsequent decline in lung characteristics. In December 2019, the World Health Organization (WHO) declared the outbreak of the radical coronavirus disease 2019 (COVID-19) as a worldwide public health crisis, which unexpectedly spread not only within China but also globally. Given that the respiration system is the primary target of the COVID-19 virus, it is crucial to investigate the impact of COVID-19 on the pathogenesis and mortality of CF patients, mainly in the context of acute respiratory distress syndrome (ARDS). Therefore, the goal of this review is to comprehensively review the present literature on the relationship between cystic fibrosis, COVID-19 contamination, and development of ARDS. Several investigations performed during the early stages of the virus outbreak have discovered unexpected findings regarding the occurrence and effectiveness of COVID-19 in individuals with CF. Contrary to initial expectancies, the rate of infection and the effectiveness of the virus in CF patients are lower than those in the overall population. This finding may be attributed to different factors, including the presence of thick mucus, social avoidance, using remedies that include azithromycin, the fairly younger age of CF patients, decreased presence of ACE-2 receptors, and the effect of CFTR channel disorder on the replication cycle and infectivity of the virus. However, it is important to notice that certain situations, which include undergoing a transplant, can also doubtlessly boost the susceptibility of CF patients to COVID-19. Furthermore, with an increase in age in CF patients, it is vital to take into account the prevalence of the SARS-CoV-2 virus in this population. Therefore, ordinary surveillance of CF patients is vital to evaluate and save the population from the capability of transmission of the virus given the various factors that contribute to the spread of the SARS-CoV-2 outbreak in this precise organization.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1356926","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T05:16:43Z","timestamp":1713331003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Occurrence of COVID-19 in cystic fibrosis patients: a review"],"prefix":"10.3389","volume":"15","author":[{"given":"Fatemeh Sadat","family":"Abolhasani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Moein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parimah","family":"Sheikhimehrabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morvarid","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Modaresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.5001\/omj.2023.10","article-title":"COVID-19 in a cystic fibrosis patient","volume":"38","author":"Al Lawati","year":"2023","journal-title":"Oman Med. J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study","volume":"20","author":"Bain","year":"2021","journal-title":"J. Cyst. Fibr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/jpm11060558","article-title":"Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants","volume":"11","author":"Baldassarri","year":"2021","journal-title":"J. Personal. Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jcf.2019.08.020","article-title":"Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis","volume":"19","author":"Barth","year":"2020","journal-title":"J. Cyst. Fibr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-021-00634-8","article-title":"Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation","volume":"2021","author":"Bekassy","year":"2021","journal-title":"Nat. Rev. Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jcf.2020.08.005","article-title":"SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis","volume":"19","author":"Berardis","year":"2020","journal-title":"J. Cyst. Fibr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-020-00909-1","article-title":"Does cystic fibrosis constitute an advantage in COVID-19 infection?","volume":"46","author":"Bezzerri","year":"2020","journal-title":"Ital. J. Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11845-023-03391-w","article-title":"Impact of COVID-19 pandemic on health care system, work, and mental well-being of people with cystic fibrosis","volume":"23","author":"Bhatnagar","year":"2023","journal-title":"Irish J. Med. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3390\/life12122087","article-title":"SARS-CoV-2 infection in patients with cystic fibrosis: what we know so far","volume":"12","author":"Biondo","year":"2022","journal-title":"Life"},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/microorganisms9010093","article-title":"SARS-CoV-2 entry genes expression in relation with interferon response in cystic fibrosis patients","volume":"9","author":"Bitossi","year":"2021","journal-title":"Microorganisms"},{"key":"B11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/jpdtsm.jpdtsm_10_22","article-title":"Cystic fibrosis: mutations, modulators and microbiology","volume":"1","author":"Blevings","year":"2022","journal-title":"J. Prev. Diagnost. Treat. Strat. Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00431-021-04345-z","article-title":"Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study","volume":"181","author":"Borch","year":"2022","journal-title":"Eur. J. Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/MCP.0000000000000823","article-title":"COVID-19 outcomes in people with cystic fibrosis","volume":"27","author":"Burgel","year":"2021","journal-title":"Curr. Opin. Pulmon. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.jcf.2022.06.006","article-title":"Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: a global observational study","volume":"21","author":"Carr","year":"2022","journal-title":"J. Cyst. Fibr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fpubh.2020.00383","article-title":"COVID-19: a multidisciplinary review","volume":"8","author":"Chams","year":"2020","journal-title":"Front. Publ. Health"},{"key":"B17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0251527","DOI":"10.1371\/journal.pone.0251527","article-title":"SARS-CoV-2 infection in cystic fibrosis: a multicentre prospective study with a control group, Italy, February-July 2020","volume":"16","author":"Colombo","year":"2021","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"Colombo","year":"2020","journal-title":"Lancet Respirat. Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s15010-021-01737-z","article-title":"Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society","volume":"50","author":"Colombo","year":"2022","journal-title":"Infection"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in COVID-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.3390\/jcm9113624","article-title":"First wave of COVID-19 in French patients with cystic fibrosis","volume":"9","author":"Corvol","year":"2020","journal-title":"J. Clin. Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","article-title":"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis","volume":"19","author":"Cosgriff","year":"2020","journal-title":"J. Cyst. Fibr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.aller.2018.12.009","article-title":"Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma","volume":"47","author":"Demirci","year":"2019","journal-title":"Allergologia et Immunopathologia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1183\/13993003.01910-2017","article-title":"Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis","volume":"51","author":"Dittrich","year":"2018","journal-title":"Eur. Respirat. J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100689","DOI":"10.1016\/j.nmni.2020.100689","article-title":"Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome","volume":"35","author":"Earhart","year":"2020","journal-title":"N. Microbes N. Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16292378","DOI":"10.22541\/au.159170711.16292378","article-title":"Could azithromycin play a role in the treatment of COVID-19? A review","volume":"2020","author":"Echeverria-Esnal","year":"2020","journal-title":"Authorea"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i3.10391","article-title":"SARS-CoV-2 infection in patients with cystic fibrosis. An overwiew","author":"Fainardi","year":"2020","journal-title":"Acta Bio Medica"},{"key":"B30","article-title":"\u201cPulmonary complications of cystic fibrosis,\u201d","volume-title":"Seminars in Respiratory and Critical Care Medicine","author":"Flume","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.arbres.2021.12.003","article-title":"The impact of COVID-19 in cystic fibrosis","volume":"58","author":"Flume","year":"2022","journal-title":"Archivos de Bronconeumologia"},{"key":"B32","first-page":"1","article-title":"SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty","volume":"2020","author":"Gaudio","year":"2020","journal-title":"Physiol. Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"22139","DOI":"10.1038\/s41598-020-77748-x","article-title":"A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment","volume":"10","author":"Ghazy","year":"2020","journal-title":"Sci. Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/cid\/ciaa709","article-title":"Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza","volume":"71","author":"Gu","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"106606","DOI":"10.1016\/j.rmed.2021.106606","article-title":"Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: a multicenter retrospective research network study","volume":"188","author":"Hadi","year":"2021","journal-title":"Respirat. Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"E1155","DOI":"10.1503\/cmaj.220620","article-title":"Severity of COVID-19 among solid organ transplant recipients in Canada, 2020\u20132021: a prospective, multicentre cohort study","volume":"194","author":"Hall","year":"2022","journal-title":"CMAJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respirat. Crit. Care Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1111\/aos.14445","article-title":"Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19","volume":"98","author":"Hong","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"153647","DOI":"10.1016\/j.prp.2021.153647","article-title":"Host factors: implications in immunopathogenesis of COVID-19","volume":"228","author":"Jafarpour","year":"2021","journal-title":"Pathol. Res. Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S324","DOI":"10.1016\/j.respe.2018.05.235","article-title":"Cystic fibrosis related diabetes before lung transplantation impacts survival but not long-term renal function","volume":"66","author":"Jardel","year":"2018","journal-title":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40779-020-0233-6","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Milit. Med. Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1183\/23120541.00411-2021","article-title":"Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe","volume":"7","author":"Jung","year":"2021","journal-title":"ERJ Open Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4161\/auto.27750","article-title":"The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections","volume":"10","author":"Junkins","year":"2014","journal-title":"Autophagy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/B978-0-12-821038-3.00055-0","article-title":"Arginine and citrulline as nutraceuticals: efficacy and safety in diseases","volume":"55","author":"Kaore","year":"2021","journal-title":"Nutraceuticals"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1002\/jmv.27160","article-title":"Polymorphisms of ACE (I\/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: a case study","volume":"93","author":"Karaka\u015f \u00c7elik","year":"2021","journal-title":"J. Med. Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"174191","DOI":"10.1016\/j.ejphar.2021.174191","article-title":"Azithromycin: immunomodulatory and antiviral properties for SARS-CoV-2 infection","volume":"905","author":"Khezri","year":"2021","journal-title":"Eur. J. Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/antibiotics11081063","article-title":"Azithromycin through the Lens of the COVID-19 treatment","volume":"11","author":"Kournoutou","year":"2022","journal-title":"Antibiotics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-0856-5","article-title":"Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response","volume":"15","author":"Lam","year":"2015","journal-title":"BMC Infect. Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1183\/09031936.01.18040692","article-title":"Lung dendritic cells and host immunity to infection","volume":"18","author":"Lambrecht","year":"2001","journal-title":"Eur. Respirat. J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"104344","DOI":"10.1016\/j.micpath.2020.104344","article-title":"The critical role of Faecalibacterium prausnitzii in human health: an overview","volume":"149","author":"Leylabadlo","year":"2020","journal-title":"Microb. Pathog"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/ppul.25850","article-title":"Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households","volume":"57","author":"Lim","year":"2022","journal-title":"Pediatr. Pulmonol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/cells11081347","article-title":"CFTR modulation reduces SARS-CoV-2 infection in human bronchial epithelial cells","volume":"11","author":"Lotti","year":"2022","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/ppul.24307","article-title":"Cystic fibrosis-related diabetes before lung transplantation is associated with lower survival but does not affect long-term renal function","volume":"54","author":"Mainbourg","year":"2019","journal-title":"Pediatr. Pulmonol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/cei.13624","article-title":"Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6","volume":"205","author":"Majka","year":"2021","journal-title":"Clin. Exp. Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"31936","DOI":"10.3390\/healthcare11131936","article-title":"Epidemiological profile of hospitalized patients with cystic fibrosis in Brazil due to severe acute respiratory infection during the COVID-19 pandemic and a systematic review of worldwide COVID-19 in those with cystic fibrosis","volume":"2023","author":"Marques","year":"2023","journal-title":"Healthcare"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-021-01528-0","article-title":"Systematic review: cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic","volume":"21","author":"Mathew","year":"2021","journal-title":"BMC Pulmon. Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J. Cyst. Fibr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev"},{"key":"B61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/ijpvm.IJPVM_277_20","article-title":"COVID-19 infection and children: a comprehensive review","volume":"11","author":"Mehrabani","year":"2020","journal-title":"Int. J. Prev. Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0022034520914246","article-title":"Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine","volume":"99","author":"Meng","year":"2020","journal-title":"J. Dental Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/cells9081845","article-title":"Cystic fibrosis defective response to infection involves autophagy and lipid metabolism","volume":"9","author":"Mingione","year":"2020","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun. Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1183\/23120541.00409-2020","article-title":"COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres","volume":"6","author":"Moeller","year":"2020","journal-title":"ERJ Open Res"},{"key":"B66","first-page":"1","volume-title":"Neutrophil Elastase Inhibitors: A Potential Prophylactic Treatment Option for SARS-CoV-2-Induced Respiratory Complications?","author":"Mohamed","year":"2020"},{"key":"B67","doi-asserted-by":"publisher","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID-19-Spain survey","volume":"170","author":"Mondejar-Lopez","year":"2020","journal-title":"Respirat. Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naehrlich","year":"2021","journal-title":"J. Cyst. Fibr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jiph.2020.05.009","article-title":"Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?","volume":"13","author":"Nilashi","year":"2020","journal-title":"J. Infect. Publ. Health"},{"key":"B70","doi-asserted-by":"publisher","first-page":"100756","DOI":"10.1016\/j.nmni.2020.100756","article-title":"Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection","volume":"37","author":"Okur","year":"2020","journal-title":"N. Microb. N. Infect"},{"key":"B71","volume-title":"Role of cellular ion channels in the BK polyomavirus life cycle","author":"Panou","year":"2018"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fimmu.2019.01486","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"277","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets cystic fibrosis: for better or worse?","volume":"21","author":"Peckham","year":"2020","journal-title":"Genes Immun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/cells9091952","article-title":"Autophagy augmentation to alleviate immune response dysfunction, and resolve respiratory and COVID-19 exacerbations","volume":"9","author":"Pehote","year":"2020","journal-title":"Cells"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am. J. Transpl"},{"key":"B76","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chest.2017.03.056","article-title":"The role of neutrophil elastase inhibitors in lung diseases","volume":"152","author":"Polverino","year":"2017","journal-title":"Chest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2","DOI":"10.7554\/eLife.87030.2","article-title":"Nebulised dornase alfa reduces inflammation and improves clinical outcomes in severe COVID-19: a randomised clinical trial","volume":"12","author":"Porter","year":"2023","journal-title":"eLife"},{"key":"B78","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00018-022-04469-x","article-title":"The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses","volume":"79","author":"Roingeard","year":"2022","journal-title":"Cell. Mol. Life Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"714027","DOI":"10.3389\/fimmu.2021.714027","article-title":"Flagellin from Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in cystic fibrosis airway epithelial cells by increasing TMPRSS2 expression","volume":"12","author":"Ruffin","year":"2021","journal-title":"Front. Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"13251","DOI":"10.1111\/jcpt.13251","article-title":"Neutrophil Elastase inhibitor (Sivelestat), may be a promising therapeutic option for Management of Acute Lung Injury\/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19","volume":"2020","author":"Sahebnasagh","year":"2020","journal-title":"Authorea"},{"key":"B81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s15010-020-01531-3","article-title":"Epidemiology of SARS-CoV-2","volume":"49","author":"Salzberger","year":"2021","journal-title":"Infection"},{"key":"B82","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jcf.2020.06.018","article-title":"No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy","volume":"19","author":"Scagnolari","year":"2020","journal-title":"J. Cyst. Fibr"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","article-title":"Electrolyte abnormalities in cystic fibrosis: systematic review of the literature","volume":"29","author":"Scurati-Manzoni","year":"2014","journal-title":"Pediatr. Nephrol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1756284820974914","DOI":"10.1177\/1756284820974914","article-title":"The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?","volume":"13","author":"Segal","year":"2020","journal-title":"Therapeut. Adv. Gastroenterol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/JVI.01387-16","article-title":"Clinical isolates of human coronavirus 229E bypass the endosome for cell entry","volume":"91","author":"Shirato","year":"2017","journal-title":"J. Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/infdis\/141.3.271","article-title":"Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases","volume":"141","author":"Smith","year":"1980","journal-title":"J. Infect. Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"18909","DOI":"10.1038\/s41598-020-75848-2","article-title":"Explaining among-country variation in COVID-19 case fatality rate","volume":"10","author":"Sorci","year":"2020","journal-title":"Sci. Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ppul.24306","article-title":"Aerosolized agents for airway clearance in cystic fibrosis","volume":"54","author":"Southern","year":"2019","journal-title":"Pediatr. Pulmonol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"L408","DOI":"10.1152\/ajplung.00225.2020","article-title":"SARS-CoV-2 (COVID-19) and cystic fibrosis","volume":"319","author":"Stanton","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJM199702133360707","article-title":"The diagnosis of cystic fibrosis","volume":"336","author":"Stern","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"42","DOI":"10.37757\/MR2021.V23.N2.4","article-title":"Implications of low-grade inflammation in SARS-CoV-2 immunopathology","volume":"23","author":"Suarez-Reyes","year":"2021","journal-title":"Medicc Rev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.clinthera.2023.01.016","article-title":"The impact of highly effective cystic fibrosis transmembrane conductance regulator modulators on the health of female subjects with cystic fibrosis","volume":"45","author":"Taylor-Cousar","year":"2023","journal-title":"Clin. Therapeut"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e23220","DOI":"10.1096\/fj.202300077R","article-title":"Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity","volume":"37","author":"Tedbury","year":"2023","journal-title":"FASEB J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13052-022-01331-5","article-title":"Dornase alfa in cystic fibrosis: indications, comparative studies and effects on lung clearance index","volume":"48","author":"Terlizzi","year":"","journal-title":"Ital. J. Pediatr"},{"key":"B96","doi-asserted-by":"publisher","first-page":"958658","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review","volume":"10","author":"Terlizzi","year":"","journal-title":"Front. Pediatr"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/children9111625","article-title":"Effect of dornase alfa on the lung clearance index in children with cystic fibrosis: a lesson from a case series","volume":"9","author":"Terlizzi","year":"","journal-title":"Children"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1021\/acsinfecdis.0c00456","article-title":"Targeting crucial host factors of SARS-CoV-2","volume":"6","author":"Tharappel","year":"2020","journal-title":"ACS Infect. Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci. Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcf.2005.05.011","article-title":"Viral respiratory infections in cystic fibrosis","volume":"4","author":"van Ewijk","year":"2005","journal-title":"J. Cyst. Fibr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0208171","DOI":"10.1371\/journal.pone.0208171","article-title":"Gut microbiota signatures in cystic fibrosis: loss of host CFTR function drives the microbiota enterophenotype","volume":"13","author":"Vernocchi","year":"2018","journal-title":"PLoS ONE"},{"key":"B102","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12931-023-02593-1","article-title":"The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review","volume":"24","author":"Vitiello","year":"2023","journal-title":"Respirat. Res"},{"key":"B103","author":"Ward","year":"2016","journal-title":"The Coalition Chronicle"},{"key":"B104","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1183\/09031936.00202311","article-title":"Viral infections trigger exacerbations of cystic fibrosis in adults and children","volume":"40","author":"Wark","year":"2012","journal-title":"Eur. Respirat. J"},{"key":"B105","doi-asserted-by":"publisher","first-page":"CD001127","DOI":"10.1002\/14651858.CD001127.pub5","article-title":"Dornase alfa for cystic fibrosis","volume":"2021","author":"Yang","year":"2021","journal-title":"Cochr. Datab. Syst. Rev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.3390\/molecules26247459","article-title":"Coronavirus infection-associated cell death signaling and potential therapeutic targets","volume":"26","author":"Yapasert","year":"2021","journal-title":"Molecules"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/17476348.2020.1787835","article-title":"COPD patients in a COVID-19 society: depression and anxiety","volume":"15","author":"Yohannes","year":"2021","journal-title":"Exp. Rev. Respirat. Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.3390\/ijms24044052","article-title":"Respiratory infection and inflammation in cystic fibrosis: a dynamic interplay among the host, microbes, and environment for the ages","volume":"24","author":"Yu","year":"2023","journal-title":"Int. J. Mol. Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.molcel.2020.10.034","article-title":"Nonstructural protein 1 of SARS-CoV-2 is a potent pathogenicity factor redirecting host protein synthesis machinery toward viral RNA","volume":"80","author":"Yuan","year":"2020","journal-title":"Mol. Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intens. Care Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41421-022-00419-w","article-title":"Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies","volume":"8","author":"Zhao","year":"2022","journal-title":"Cell Disc"},{"key":"B113","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12275-021-1206-5","article-title":"Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge","volume":"59","author":"Zhou","year":"2021","journal-title":"J. Microbiol"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1356926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T05:18:05Z","timestamp":1713331085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1356926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":113,"alternative-id":["10.3389\/fmicb.2024.1356926"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1356926","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"article-number":"1356926"}}